Funding source: This work was supported by program for Changjiang Scholars and Innovative Teams in Universities, Ministry of Education, China (IRT0760).
Thalidomide improves clinical symptoms of primary cutaneous amyloidosis: report of familiar and sporadic cases
Article first published online: 13 MAR 2013
© 2013 Wiley Periodicals, Inc.
Special Issue: Update on Understanding and Managing Chronic Wounds
Volume 26, Issue 3, pages 263–266, May/June 2013
How to Cite
An, Q., Zhang, L., Zheng, S., Lin, J., Hong, Y., Chen, H.-D. and Gao, X.-H. (2013), Thalidomide improves clinical symptoms of primary cutaneous amyloidosis: report of familiar and sporadic cases. Dermatologic Therapy, 26: 263–266. doi: 10.1111/j.1529-8019.2013.01548.x
Conflict of interest: None.
- Issue published online: 6 JUN 2013
- Article first published online: 13 MAR 2013
- Changjiang Scholars and Innovative Teams in Universities, Ministry of Education, China. Grant Number: IRT0760
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.